Foundation for Opioid Response Efforts Announces Initiative to Help Schools Access Medicaid Funding for Substance Misuse Prevention Programs
October 31, 2022 14:22 ET | Foundation for Opioid Response Efforts
New York, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Medicaid funding is available to expand school-based substance misuse prevention programs, however many school districts have limited access to the...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
September 26, 2022 09:00 ET | Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OAK pain completed enrollment with last patient (n=120) dosedNo limiting toxicities have been encountered during the trial to date. Patients are now being monitored for...
Stop Opioid Overdoes Naloxone
Fentanyl Drives Fatal Overdoses to Over 107,000 Annually in the U.S. - Healthcare Providers' Effort to Fight Back
August 24, 2022 09:00 ET | Cordant Health Solutions
PORTLAND, Ore., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Cordant Health Solutions®, a leader in providing innovative tools for addiction treatment programs, is partnering with addiction treatment providers...
Featured Image for Experimental Biology and Medicine
Potential Risk for Methadone Treatment in Pregnancy
July 13, 2022 10:00 ET | Experimental Biology and Medicine
WASHINGTON, July 13, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 12, June, 2022) identifies a potential risk to using Methadone...
“Opioid-free”: Innovative ACL Surgery That Doesn’t Rely On Opioid Pain Pills
June 09, 2022 09:30 ET | WellSpan Health
York, Pa., June 09, 2022 (GLOBE NEWSWIRE) -- A WellSpan orthopedic surgeon is performing surgery on all patients under the age of 25 without prescribing opioids, just one method WellSpan caregivers...
Days Without Art 2008
Boston Artists, Activists to Lead Healing Walk to Mark Toll of Multiple Pandemics
November 18, 2021 14:00 ET | SPOKE Arts
BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- A coalition of artists, activists, and local officials invite the Greater Boston community to join a Days Without Art Healing Walk on the evening of...
The Reverend Dr. LaKeesha Walrond Joins Board of Directors of Foundation for Opioid Response Efforts (FORE)
September 22, 2021 11:16 ET | Foundation for Opioid Response Efforts
New York, Sept. 22, 2021 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced that The Reverend Dr. LaKeesha Walrond, President of the New York Theological Seminary...
First-in-human clinical trial for a vaccine to treat opioid use disorders enrolls first patients
September 07, 2021 08:30 ET | University of Minnesota Medical School
MINNEAPOLIS/ST. PAUL, Sept. 07, 2021 (GLOBE NEWSWIRE) -- The first patients have been enrolled in a phase 1 randomized placebo-controlled clinical trial to study a therapeutic vaccine for opioid use...
FORE and APF logos.jpg
CDC Updates List of Health Conditions that Can Increase the Risk of Severe Illness from COVID-19 to include Substance Use Disorders New York & Bethesda, May 10, 2021 (GLOBE NEWSWIRE) -- Health officials have released an update that individuals with substance use disorders (SUD) are at a heightened risk for serious...
Figure 1:
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
September 28, 2020 09:00 ET | Sorrento Therapeutics, Inc.
Phase 1b safety data at 6 month post-administration and Day 84 efficacy data available for all patients enrolled.No dose limiting toxicities at any of the doses tested (up to 30 ug) at 6 months...